Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

White House Credits Eli Lilly With Help In Final Deal On Patent Reform Bill

This article was originally published in The Pink Sheet Daily

Executive Summary

At President Obama's urging the CEOs of Lilly and Cisco met with Commerce Department officials to hammer out their differences to get the legislation through Congress.
Advertisement

Related Content

Will Inter Partes Review Go Away? Supreme Court Weighs Fate
BioMarin Clears Path For Pompe Treatment After Knocking Out Genzyme Patents
Patent Troll Bill Clears House; Provisions Problematic For PhRMA Remain
Patent Bill Aims For Trolls, But Will It Snare Rx Firms Instead?
Patent Reform Modifications Clear Congress, But Leave Two Contentious Issues Unresolved
Patent Power In Congress Will Shift Some In House, Less In Senate After Election
Patent Reform Speeds Drug Development, At Least At The Signing Ceremony
Patent Reform Speeds Drug Development, At Least At The Signing Ceremony
It's All Over But The Signing: Patent Reform Bill Passes Senate Without Amendments
It's All Over But The Signing: Patent Reform Bill Passes Senate Without Amendments

Topics

Advertisement
UsernamePublicRestriction

Register

PS072776

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel